Dong Song Wei

Corporate Secretary at SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.

Net worth: 30 049 $ as of 2024-04-29

51 year

Health Technology

Profile

Dong Song Wei currently works at Sinopharm YiXin Pharmaceutical Co., Ltd., as Director and Shanghai Shyndec Pharmaceutical Co., Ltd., as Board Secretary & Vice President from 2012.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. CLASS A 0.00%	2023-04-13	20,000 ( 0.00% )	30 049 $	2024-04-29

Dong Song Wei active positions

Companies	Position	Start
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	Corporate Secretary	2012-01-08
Sinopharm YiXin Pharmaceutical Co., Ltd. Sinopharm YiXin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Holding A-Think Pharmaceutical Co., Ltd. engages in the manufacture and sale of injection mannose peptide. Its products and services include Octreotide acetate injection, Adenosine monophosphate for injection, Leucovorin for injection, Ondansetron hydrochloride injection, Sodium norcantharidin for injection, Norcantharidin tablet, Total saponin of ginseng stem and leaf tablets, Ginseng stems and leaves total saponin capsules, Vinorelbine tartaric acid for injection, and Poly-long-acting anti-bacterial membrane liquid material. The company was founded on December 10, 1997 and is headquartered in Changchun, China.	Director/Board Member	-

All active positions of Dong Song Wei

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Dong Song Wei's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	Health Technology

Private companies	1
Sinopharm YiXin Pharmaceutical Co., Ltd. Sinopharm YiXin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Holding A-Think Pharmaceutical Co., Ltd. engages in the manufacture and sale of injection mannose peptide. Its products and services include Octreotide acetate injection, Adenosine monophosphate for injection, Leucovorin for injection, Ondansetron hydrochloride injection, Sodium norcantharidin for injection, Norcantharidin tablet, Total saponin of ginseng stem and leaf tablets, Ginseng stems and leaves total saponin capsules, Vinorelbine tartaric acid for injection, and Poly-long-acting anti-bacterial membrane liquid material. The company was founded on December 10, 1997 and is headquartered in Changchun, China.	Health Technology